KGK Science Inc.

KGK Science Inc. is a contract research organization (CRO) specializing in the nutraceutical, cannabis, hemp, and psychedelic industries. Founded in 1997, the company provides end-to-end clinical research trials and comprehensive regulatory support. They design customized clinical trials to substantiate safety and efficacy claims, utilizing advanced methodologies such as virtual trials and in-house biostatistical analysis. Their services are supported by a multidisciplinary team of scientific researchers, toxicologists, and regulatory experts, including former federal regulators, who assist clients in navigating complex global regulatory landscapes, including submissions to the FDA, Health Canada, and other international bodies.

By managing the entire product lifecycle from preclinical study design and safety assessments to final regulatory approval and publication, KGK helps brands differentiate their products and enter markets with scientifically verified evidence. Their work addresses critical challenges for sponsors, such as participant recruitment—supported by a proprietary database of over 45,000 participants—and the mitigation of regulatory risk. These services empower companies to secure product licenses, substantiate marketing claims, and ensure compliance with stringent industry standards, ultimately facilitating the successful commercial launch of natural health products.